EBC trains early-stage researchers to become a voice for neuroscience research throughout their careers
In the context of the Marie Skłodowska-Curie actions on Innovative Training Networks funded by the Horizon 2020 programme, EBC organised a workshop on the role of science in the European policy-making process. The workshop addressed to a group of early-stage researchers aimed to empower them with ways to become a voice for neuroscience research throughout their careers. Participants were introduced [...]
Global Webinar Series 2020-2021: Part 6 – Outcome
The Hydrocephalus Society is delighted to announce the Hydrocephalus Society Global Webinar Series on iNPH 2020-2021! A series of 6 monthly webinars will take place, beginning from November 2020 until April 2021. In these challenging times, our duty is to support our community in all ways possible. For this reason, the Hydrocephalus Society board of directors [...]
Brain Innovation Days: Fast-tracking brain innovation in times of COVID-19
The last 14 months have been a most testing time for the world in general and for global health in particular. COVID-19 took the world by surprise as weaknesses were exposed in public health systems' preparedness to face pandemics and we continue to face the consequences over a year on. However, the emergence of [...]
“Brain and machine: Improving MS care in a digital age”
The rapid development of COVID-19 vaccines is perhaps the clearest example of cumulative medical innovationㅡand its undisputed power to transform lives. But scientific innovation has not been limited to the race for immunity. From telemedicine and portable diagnostics to digital therapeutics and blockchain, digital technologies are reshaping health-care delivery―and could play a transformative role [...]
Open co-design workshop on next generation tools to manage Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Started on January 2021, the 4 years Horizon 2020 BRAINTEASER project seeks to exploit the value of artificial intelligence, big data—including those related to health, lifestyle habits and environment—, low-cost sensors and smart apps to support patients living with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) and their caregivers. Its goal is to develop [...]
Value of Treatment 2 Synthesis Meeting
The European Brain Council (EBC) is pleased to invite you for the Value of Treatment 2 (VOT 2) Synthesis Meeting, to be held virtually on 8 June 2021 (13:00-17:00 CET). Experts participating in the research will present a synthesis of the results so far and examine the most critical issues in brain diseases in Europe from different perspectives including policymakers, innovators, academia [...]
EMSP 2021 Virtual Conference
The EMSP 2021 Annual Conference will be held virtually and will be taking place online on the 9th, 10th and 11th June. The theme of this year’s conference is “MS Care in a Changing World”, with special focus on the healthcare professionals and non-professional caregivers for MS patients, and how everyone has had to adapt [...]
Myalgic Encephalomyelitis in Europe: Roundtable of European Stakeholders and Policymakers
Following joint planning sessions, EMEA and EFNA (European Federation of Neurological Associations) are arranging a multi-stakeholder, roundtable meeting on Myalgic Encephalomyelitis (ME/CFS) in Europe. The meeting will bring together a variety of initial stakeholders in Europe, including clinicians, researchers, policymakers, industry and patient representatives from EMEA's members, in order to create a better understanding of [...]
EBC at the Africa – Europe Science and Innovation Platform
AERAP is a response to the call of the European Parliament, through the adoption of its Written Declaration 45 “on Science Capacity Building in Africa: promoting European-African radio astronomy partnerships”. This call was repeated by the Heads of State of the African Union, through their decision “Assembly/AU/Dec.407 CXVIII”, for radio astronomy to be a priority [...]
Patient safety and informed consent: The importance of good off-label use practices
In 2016, the Declaration for Good Off-Label Use Practice was launched, supported by a coalition of European organisations dedicated to ensuring that high standards of patient care are upheld and that progress in medical research and innovation is achieved. The GOLUP Declaration recommends that off-label use of medicinal products should only occur if certain criteria, drawn together [...]